Regional Transplant Programs Study of Immunosuppressive Therapy Related Toxicities in Renal Transplant Recipients Managed at Regional or Satellite Community Nephrology Clinics.

Trial Profile

Regional Transplant Programs Study of Immunosuppressive Therapy Related Toxicities in Renal Transplant Recipients Managed at Regional or Satellite Community Nephrology Clinics.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Tacrolimus (Primary) ; Ciclosporin; Immunosuppressants
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 29 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top